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Abstract
Background: The present study evaluated the SD Bioline Malaria Ag 05FK40 (SDFK40), a three-band RDT detecting
Plasmodium falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) and pan Plasmodium-specific pLDH (pan-
pLDH), in a reference setting.
Methods: The SDFK40 was retrospectively and prospectively tested against a panel of stored (n = 341) and fresh
(n = 181) whole blood samples obtained in international travelers suspected of malaria, representing the four
Plasmodium species as well as Plasmodium negative samples, and compared to microscopy and PCR results. The
prospective panel was run together with OptiMAL (Pf-pLDH/pan-pLDH) and SDFK60 (histidine-rich protein-2 (HRP-
2)/pan-pLDH).
Results: Overall sensitivities for P. falciparum tested retrospectively and prospectively were 67.9% and 78.8%,
reaching 100% and 94.6% at parasite densities >1,000/μl. Sensitivity at parasite densities ≤ 100/μl was 9.1%. Overall
sensitivities for Plasmodium vivax and Plasmodium ovale were 86.7% and 80.0% (retrospectively) and 92.9% and
76.9% (prospectively), reaching 94.7% for both species (retrospective panel) at parasite densities >500/μl. Sensitivity
for Plasmodium malariae was 21.4%. Species mismatch occurred in 0.7% of samples (3/411) and was limited to
non-falciparum species erroneously identified as P. falciparum. None of the Plasmodium negative samples in the
retrospective panel reacted positive. Compared to OptiMAL and SDFK60, SDFK40 showed lower sensitivities for P.
falciparum, but better detection of P. ovale. Inter-observer agreement and test reproducibility were excellent, but
lot-to-lot variability was observed for pan-pLDH results in case of P. falciparum.
Conclusion: SDFK40 performance was poor at low (≤ 100/μl) parasite densities, precluding its use as the only
diagnostic tool for malaria diagnosis. SDFK40 performed excellent for P. falciparum samples at high (>1,000/μl)
parasite densities as well as for detection of P. vivax and P. ovale at parasite densities >500/μl.
Background
Despite increasing efforts in prevention and treatment,
malaria remains a major cause of death, especially in
sub-Saharan Africa [1]. Prompt and accurate diagnosis
is necessary to start adequate treatment. Microscopy,
the gold standard for malaria diagnosis, is labor-inten-
sive and requires considerable expertise [2,3]. The use of
malaria rapid diagnostic tests (RDTs) is recommended
by the World Health Organization (WHO) when reliable
microscopy is not available [4]. In non-endemic settings,
where microscopic expertise is lacking due to low inci-
dence, malaria RDTs are of value for the diagnosis of
malaria and they provide information about the involve-
ment of Plasmodium falciparum. In a recent external
quality control session, 72.7% of 183 Belgian laboratories
offering malaria diagnosis declared to use RDTs as a
tool for diagnosis, and their use is recommended if per-
formed in conjunction with microscopy [5]. RDTs are
handheld cassettes detecting Plasmodium parasites by
an antibody-antigen reaction. They are available in
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Targeted antigens are specific to P. falciparum (histi-
dine-rich protein-2 (HRP-2) and P. falciparum-specific
parasite lactate dehydrogenase (Pf-pLDH)), specific to
Plasmodium vivax (P. vivax-specific pLDH (Pv-pLDH))
or common to the four Plasmodium species (pan-pLDH
or aldolase). Most RDTs detecting P. falciparum target
HRP-2, only few of them are directed to Pf-pLDH [6,7].
However, Pf-pLDH based RDTs have advantages over
the HRP-2 based RDTs, such as the rapid clearance of
pLDH after successful treatment [8], the absence of the
prozone effect [9] and the fact that recently observed
HRP-2 gene deletions impede detection of P. falciparum
by HRP-2 based RDTs [10]. For routine diagnosis
of malaria at the Institute of Tropical Medicine
(ITM), Antwerp, Belgium, a reference laboratory in a
non-endemic setting, both a HRP-2 and a Pf-pLDH
RDT are performed.
SD Bioline Malaria Ag 05FK40 (Standard Diagnostics
Inc., Hagal-Dong, Korea), further referred to as SDFK40,
i sao n e - s t e pt h r e e - b a n dR D Tt a r g e t i n gP f - p L D Ha n d
pan-pLDH. The present study was performed to evalu-
ate the test characteristics of the SDFK40 and determine
its possible role in routine diagnosis.
Methods
Study design
The study was performed in a non-endemic reference
setting and consisted of two parts: a retrospective study
on stored clinical samples and a prospective study in
which the SDFK40 was challenged to fresh samples and
r u ns i d et os i d et ot w oo t h e rR D T s ,O p t i M A La n d
SDFK60, which were used as part of routine diagnostic
procedure. The reference method was microscopy cor-
rected by PCR for malaria diagnosis and Plasmodium
species identification; for determination of parasite den-
sity, microscopy was the reference method. The study
design was in compliance with the STARD guidelines
for presentation of diagnostic studies [11].
Patients and materials
EDTA anti-coagulated blood samples were obtained in
patients clinically suspected of malaria. Most patients
presented at the outpatient clinic of ITM. A small part
of the samples had been submitted for confirmation to
ITM by other Belgian laboratories in the scope of its
reference function.
For the retrospective evaluation, a selection was made
out of a collection of stored whole blood samples com-
prising the four human Plasmodium species at different
parasite densities. Mixed infections were not included.
In addition, Plasmodium negative samples obtained in
patients suspected of malaria were included: these sam-
ples were microscopy and PCR-negative, and showed no
test lines with any of the RDTs used in routine diagno-
sis (OptiMAL and SDFK60). The samples had been
obtained between January 2002 and April 2009 and had
been stored at -70°C. Samples collected at ITM
remained at room temperature (below 25°C) for a maxi-
mum of 8 hours before storing at -70°C. Samples send
to ITM by other laboratories were exposed to ambient
temperatures during the time of shipment which
was generally less than 24 hours with a maximum of
48 hours.
The prospective part was performed between March
2009 and October 2010 and included first samples of
each patient for which microscopy or one of the both
routinely used RDTs (OptiMAL and SDFK60) were
positive for malaria.
Reference method
All samples were assessed by an expert microscopist for
diagnosis of malaria, species identification and determi-
nation of parasite density as described previously [12].
Positive or doubtful results were repeated and confirmed
by a second, blinded, expert microscopist. PCR was per-
formed on whole blood samples for which microscopy
or RDT was positive: for the retrospective part real-time
PCR was adapted from Rougemont et al [12,13], for the
prospective study a four-primer real-time PCR was per-
formed [14]. For species identification, the result of
microscopy corrected by PCR results was used as the
reference method.
Test platforms
The SDFK40 is a lateral flow antigen detection test in a
cassette format, targeting Pf-pLDH and pan-pLDH. In
case of absence of the control line the test is considered
invalid and has to be repeated. A unique positive Pf-
pLDH line represents a P. falciparum infection whereas
a unique pan-pLDH line indicates an infection with one
or more of the non-falciparum species. The presence of
both test lines indicates either an infection with P. falci-
parum or a mixed infection with P. falciparum and one
or more of the non-falciparum species.
For the evaluation of the SDFK40, RDT kits from sev-
eral lot numbers were used: in the retrospective study
lot numbers R081005 (n = 277) and R081006 (n = 64)
were used, for the prospective evaluation lot numbers
BD8002 (n = 68), BD9001 (n = 11) and R081006 (n =
101) were used. All tests had been performed at last
three months before the expiry date.
The OptiMAL
® pLDH (Pan, Pf) (Diamed AG Swit-
zerland), further referred to as OptiMAL, is one of the
first released three-band RDTs, targeting Pf-pLDH and
pan-pLDH. The SD Bioline Ag Pf/Pan 05FK60 (Stan-
dard Diagnostics Inc.), further referred to as SDFK60, is
a three-band RDT targeting HRP-2 and pan-pLDH and
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stored between 18°C and 24°C. Malaria diagnosis at
ITM is accredited according to NBN EN ISO
15189:2007.
Test procedures
RDTs were performed according to the manufacturer’s
instructions except that a transfer pipette (Finnpipette,
Helsinki, Finland) was used instead of the plastic trans-
fer devices supplied in the kit. Reading of the test results
was carried out at daylight assisted by an electric bulb.
For the retrospective study, readings were subsequently
performed by three trained observers, of whom the first
was the one performing the test. Observer 1 read the
test results after 20 minutes followed by observers 2 and
3 in ten additional minutes, still within the reading time
mentioned by the manufacturer’s instructions (20-30
minutes). The observers were blinded to each others’
readings and to the results of microscopy and PCR.
To assess line intensities, a scoring system of five cate-
gories was used as described previously [12]: none (no
line visible), faint (barely visible line), weak (paler than
the control line), medium (equal to the control line) or
strong (stronger than the control line). The test results
were based on consensus agreement, i.e. an identical
result read by at least two out of three observers. In
case of no consensus the result of the first reader was
considered.
Inter-observer agreement was evaluated by determin-
ing overall agreement and kappa values for both the
results in terms of positive and negative readings as well
as for line intensities. To assess test reproducibility, 15
retrospective samples representing all species at variable
parasite densities were tested on five consecutive
occasions.
For the prospective study, the results of the routine
diagnostic work-up were considered: the laboratory
technician performing microscopy also performed the
RDTs. RDT results were generally read before micro-
scopy results were available. Only the results of the first
observer were considered as a second and third were
not always available within the given time. Results were
recorded as test line intensities.
Statistical analysis
The interpretation of test results for P. falciparum and
the non-falciparum species is shown in Table 1. Sam-
ples with pure gametocytaemia were included among
the P. falciparum species. Sensitivity and specificity were
calculated with 95% confidence intervals (C.I.). Propor-
tions were assessed for statistical significance using the
Pearson Chi-square test, or in case of small sample size,
the two-tailed Fisher’s exact test. A p-value < 0.05 was
considered significant.
Cramer’s V for categorical variables was used to assess
strength of associations between parasite densities and
line intensity readings. Inter-observer agreements for
line intensities and positive and negative test results
were expressed by kappa values for each pair of obser-
vers and by the percentage of overall agreement between
the three observers.
Ease of use
The technicians performing the tests evaluated the
SDFK40 kit’s content and instructions for clarity, and
problems and incidents during test performance were
consequently recorded.
Ethical review
The study was approved by the Institutional Review
Board of ITM and by the Ethical Committee of Antwerp
University, Belgium.
Results
Sample collection
The retrospective study included a selection of 341 sam-
ples obtained in 341 patients. Their median age was
34 years (range 6 months - 84 years) and eight patients
(2.3%) were children under the age of five years. The
male-to-female ratio was 2.25:1. The travel history was
known in 86.5% (295/341) of samples: 88.1% (260/295)
of patients had recently returned from Sub-Saharan
Africa, 8.8% from Asia and 3.1% from Latin America.
Samples consisted of all four Plasmodium species at dif-
ferent parasite densities (Tables 2, 3 and 4). For P. falci-
parum samples, the median parasite density was 1,115/
μl (range 0.1 - 1,000,000/μl). For P. vivax this was 969/
μl (range 60 - 32,000/μl), for P. ovale 1,331/μl( r a n g e
19 - 5,930/μl) and for P. malariae 645/μl( r a n g e0 . 1-
9,900/μl ) .T w oo u to f3 0P C R - c o n f i r m e dP. vivax sam-
ples had originally been diagnosed by microscopy as
P. ovale, whereas 5/30 P. ovale samples had originally
been diagnosed as P. vivax.
The panel of prospective samples (n = 181) was
obtained in 180 patients, one patient had two episodes
one year apart. The median age was 37 years (range
5 months - 77 years) and 3/180 (1.7%) patients were chil-
dren under the age of five years. The male-to-female
ratio was 1.95:1. The travel history was known in 82.2%
(145/180) of samples, of which the majority (81.4%, 118/
1 4 5 )h a db e e no b t a i n e di np a t i e n t sr e t u r n e df r o mS u b -
Saharan Africa. Species and parasite densities are listed in
Tables 2 and 5, median parasite density for P. falciparum
samples was 3,993/μl( r a n g e1 3-8 6 7 , 7 8 8 / μl), for P. vivax
3,367.5/μl (range 15 - 24,563/μl) and for P. ovale 1,904/μl
(range 51 - 5,310/μl). Two PCR-confirmed negative sam-
ples had originally been diagnosed by microscopy as
P. falciparum with very low parasite densities (13/μl and
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sample had originally been concluded as negative by
microscopy and was hence assigned to the category of
P. falciparum with parasite density 0-100/μl. There
was one mixed P. falciparum/P. malariae infection
that had originally been diagnosed as P. falciparum.
This sample was not considered for calculation of RDT
accuracy.
Test characteristics
No invalid test results were observed during both the
retrospective and prospective studies except for a single
test carried out during reproducibility testing. In two
cassette blisters, discolored (pink) desiccant was found
(indicating humidity saturation), they were replaced by
other cassettes. Tables 2 shows the number of positive
and negative test lines for all species. P. falciparum posi-
tive samples generated both visible Pf-pLDH and pan-
pLDH test lines in 94.6% (105/111) and 80.6% (87/108)
of the retrospective and prospective samples respectively
(p = 0.0016). Twenty out of 21 prospectively tested
P. falciparum samples that reacted only with the
Pf-pLDH line had been assessed with tests of the same
lot number (R081006). For this lot number a single
Pf-pLDH line was observed in 29.9% (20/67) of positive
tested P. falciparum samples, compared to 2.9% (1/34)
for lot number BD8002 (p = 0.007), and none out of
7 for lot number BD9001 (p = 0.339). In the retrospec-
tive part all but one P. falciparum samples were tested
with lot number R081005, in which a significant lower
percentage (5.4%, 6/111) of positive samples generated a
single Pf-pLDH line compared to lot number R081006
(p < 0.0002).
T a b l e s3a n d4s h o wt h et e s tc h a r a c t e r i s t i c sf o rt h e
retrospective samples. For P. falciparum, overall sensi-
tivity was 67.9% ranging from 9.1% at parasite densities
Table 1 Interpretation of test results
For P. falciparum
Test Line(s) visible Species identification by microscopy corrected by PCR
P. falciparum
† P. vivax, P. ovale, P. malariae/no parasites detected
Only Pf-pLDH or both Pf-pLDH and pan-pLDH True positive Species mismatch**/false positive
No test line/only pan-pLDH False negative/species mismatch* True Negative
For the non-falciparum species
Test Line(s) visible Species identification by microscopy corrected by PCR
P. vivax, P. ovale or P. malariae P. falciparum
†/no parasites detected
Only pan-pLDH True positive Species mismatch*/false positive
No test line/only Pf-pLDH or both Pf-pLDH and pan-pLDH False negative/species mismatch** True Negative
* P. falciparum diagnosed as non-falciparum species.
** Non-falciparum species diagnosed as P. falciparum or as a mixed infection with P. falciparum.
† Including samples with pure gametocytemia.
Table 2 Test lines visible for the SDFK40
Samples of the retrospective panel (n = 341)
Samples Both Pf-pLDH and pan-pLDH lines Only Pf-pLDH line Only pan-pLDH line No test line observed
P. falciparum (n = 172) 105 6 - 61
P. vivax (n = 30) - - 26 4
P. ovale (n = 30) - - 24 6
P. malariae (n = 14) 2* - 3 9
Negative
‡ (n = 95) - - - 95
Samples of the prospective panel (n = 180)
Samples Both Pf-pLDH and pan-pLDH lines Only Pf-pLDH line Only pan-pLDH line No test line observed
P. falciparum (n = 137) 87 21 - 29
P. vivax (n = 14) - - 13 1
P. ovale (n = 13) - 1* 10 2
P. malariae (n = 1) - - - 1
Negative
§ (n = 15) 2
† 3
† -1 0
* Species mismatch.
† False positive result.
‡ PCR and microscopy negative, routinely tested RDTs negative.
§ PCR and microscopy negative, routinely tested RDTs (Optimal and/or SDFK60) positive.
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100/μl and 1,000/μl respectively. False negative results
only occurred at parasite densities below 1,000/μl, of
which 39.2% (20/51) had parasite densities lower than
100/μl, and in 10/13 samples with pure gametocytaemia.
Sensitivity for the non-falciparum species combined was
71.6%, reaching 84.8% at parasite densities >500/μl. For
P. vivax, P. ovale and P. malariae overall sensitivities
were 86.7%, 80.0% and 21.4% respectively, increasing to
94.7% at parasite densities >500/μl for both P. vivax and
P. ovale. For P. malariae, there were not enough sam-
ples to calculate sensitivity at parasite densities >500/μl.
Table 5 shows the sensitivity of the SDFK40 when
evaluated prospectively. Sensitivities were slightly higher
compared to the retrospective results: overall sensitiv-
ities for P. falciparum and for the non-falciparum spe-
cies combined were 78.8% and 82.1% respectively. As
for the retrospective study, sensitivities were higher at
increasing parasite densities. Of note, 5/93 P. falciparum
samples with parasite densities >1,000/μl gave false
negative results; the highest parasite density among
these samples was 3,212/μl.
Species mismatch occurred in three samples, repre-
senting 0.7% of the pooled retrospective and prospective
Plasmodium positive samples (n = 411): two P. malariae
samples (parasite density of 62/μl and 9,900/μl) and one
P. ovale sample (parasite density 113/μl) reacted not
only with the pan-pLDH line, but also showed a faint
Pf-pLDH line.
Compared to the OptiMAL and the SDFK60 (Table
6), the SDFK40 had a significant lower sensitivity for
detection of P. falciparum (p = 0.004 and p < 0.0001
respectively). For the non-falciparum species combined,
overall sensitivity of the SDFK40 tended to be higher
compared to the OptiMAL and the SDFK60, though not
statistically significant. Of note, the SDFK40 performed
significantly better in the detection of P. ovale compared
to the OptiMAL (p = 0.005) and tended to perform bet-
ter than the SDFK60 (p = 0.226). The P. vivax and
P. ovale samples that were not detected by the SDFK40
in the prospective part (n = 3) had low parasite densities
(51/μl, 176/μl and 304/μl) and were tested with the
same lot number (R081006), as well as the single P.
malariae sample (parasite density 1,920/μl) that tested
negative.
The mixed P. falciparum/P. malariae infection was
found in a 11-year old child returning from Cameroon
and had a parasite density of 23/μl .T h es a m p l ew a s
Table 3 Sensitivities and specificity of the SDFK40 for the detection of P. falciparum, retrospective samples
Results of microscopy corrected by PCR Number Identified as P. falciparum by SDFK40 % Sensitivity (95% C.I.) % Specificity (95% C.I.)
All P. falciparum samples 172 111 67.9 (60.1-75.1)
Pure gametocytemia 13 3 23.1 (5.0-23.8)
Asexual parasite density 0-100/μl 22 2 9.1 (1.1-29.2)
Asexual parasite density 101-1,000/μl 55 24 43.6 (30.3-57.7)
Asexual parasite density >1,000/μl 82 82 100.0 (95.6-100.0)
Asexual parasite density >100/μl 137 106 77.4 (69.5-84.1)
All other species and no parasites seen 169 2* 98.8 (95.8-99.9)
* Both were P. malariae samples.
Table 4 Sensitivities and specificity of the SDFK40 for the detection of non-falciparum species, retrospective samples
Results of microscopy corrected by
PCR
Number Identified as non-falciparum species by
SDFK40
% Sensitivity (95%
C.I.)
% Specificity (95%
C.I.)
All non-falciparum species combined 74 53 71.6 (60.0-81.5)
Parasite density ≤ 500/μl 28 14 50.0 (30.7-69.4)
Parasite density > 500/μl 46 39 84.8 (71.1-93.7)
P. vivax samples, total 30 26 86.7 (69.3-96.2)
Parasite density ≤ 500/μl 11 8 79.7 (39.0-94.0)
Parasite density > 500/μl 19 18 94.7 (74.0-99.9)
P. ovale samples, total 30 24 80.0 (61.4-92.3)
Parasite density ≤ 500/μl 11 6 54.6 (23.4-83.3)
Parasite density > 500/μl 19 18 94.7 (74.0-99.9)
P. malariae samples, total* 14 3 21.4 (4.7-50.8)
P. falciparum and negative samples,
total
267 0 100.0 (97.9-100)
* Too few samples to calculate sensitivity according to parasite density.
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by OptiMAL, and as a single P. falciparum infection by
the SDFK60.
In the retrospective study none of the 95 Plasmodium
negative samples generated positive test results (Table 2).
I nt h ep r o s p e c t i v es t u d y ,t h e r ew e r ef i v ef a l s ep o s i t i v e
results among the 15 samples that were microscopy and
PCR negative but positive for one or both routinely per-
formed RDTs (Tables 2). Two of these samples tested
positive for Schistosoma antibodies, one patient had
been partially treated for malaria and the remaining two
samples were from a patient (tested in 2009 and 2010
after two different journeys) in whom the RDT results
were interpreted as false positive without a plausible
explanation.
Presence and intensity of test lines
For both test lines there was a correlation between para-
site density and line intensity readings, though higher
for the retrospective samples (Pf-pLDH: V = 0.6622 and
Table 5 Sensitivity of the SDFK40 according to parasite density, prospective samples
Results of microscopy corrected by PCR Number Correctly identified by SDFK40 % Sensitivity (95% C.I.)
All P. falciparum samples 137 108 78.8 (75.3-81.1)
Pure gametocytaemia 7 3 42.9 (9.9-81.6)
Asexual parasite density 0-100/μl 11 1 9.1 (2.3-41.3)
Asexual parasite density 101-1,000/μl 26 16 61.5 (40.6-79.8)
Asexual parasite density >1,000/μl 93 88 94.6 (87.9-98.2)
Asexual parasite density >100/μl 119 104 87.4 (80.1-92.8)
All non-falciparum species combined 28 23 82.1 (72.9-82.1)
Parasite density ≤ 500/μl 6 2 33.3 (4.3-77.7)
Parasite density > 500/μl 22 21 95.5 (77.2-99.9)
Table 6 Diagnostic accuracy of the different RDTs for each species, prospective samples
Species RDT brand Number of samples tested Correctly identified by RDT (number) % Sensitivity (95% CI)
P. falciparum SDFK40 137 108 78.8 (75.3-81.1)
OptiMAL 137 125 91.2 (87.7-93.9)
SDFK60 137 136 99.3 (96.0-99.9)
Non-falciparum SDFK40 28 23 82.1 (72.9-82.1)
OptiMAL 28 17 60.7 (40.6-78.5)
SDFK60 28 20 71.4 (51.3-86.8)
P. vivax SDFK40 14 13 92.9 (66.1 - 99.8)
OptiMAL 14 14 100 (76.8-100)
SDFK60 14 13 92.9 (66.1 - 99.8)
P. ovale SDFK40 13 10
‡ 76.9 (46.2-95.0)
OptiMAL 13 2 15.4 (1.9-45.6)
SDFK60 13 6 46.2 (19.2-74.9)
P. malariae* SDFK40 1 0
OptiMAL 1 1
SDFK60 1 1
Plasmodium negative
† SDFK40 15 10
OptiMAL 15 3
SDFK60 15 4
* Too few samples to calculate sensitivity.
† Included samples were negative by microscopy and PCR, but positive by the OptiMAL and/or the SDFK60.
‡ Incorrect diagnosis consisted of two samples diagnosed as Plasmodium negative and one sample diagnosed as a single P. falciparum or a mixed infection of
P. falciparum with one or more of the non-falciparum species.
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V = 0,4263, both p < 0.0001). Among the pooled retro-
spective and prospective P. falciparum samples, 17.8%
(39/219) of the positive Pf-pLDH test lines were read as
faint. For the pooled non-falciparum samples, faint test
lines were observed in 22.8% (18/79) of positive pan-
pLDH lines. For both Pf-pLDH and pan-pLDH test
lines, medium and strong intensities occurred exclu-
sively at parasite densities above 1,000/μl, except for one
sample with pure gametocytaemia.
Reproducibility and inter-observer agreement
For both Pf-pLDH and pan-pLDH test lines overall
agreement and kappa values between pairs of observers
were excellent for both positive and negative readings (≥
94.7%, kappa values ≥ 0.92) and line intensity readings
(≥ 86.5%, kappa values ≥ 0.84). Test results were repro-
ducible and all discordances in line intensity occurred
within one category of difference.
Ease of use
The SDFK40 was evaluated as easy to use, with an
excellent clearance of the background and clearly visible
test lines. In most tests the background became blurred
after 60 minutes and test lines were no longer visible.
The test instructions in the package insert were clear
and accompanied by well-designed pictures. The part
presenting invalid test results (absence of control line)
failed to demonstrate pictures of a pan line without con-
trol line as well as both test lines without control line.
Discussion
In this study, the performance of the malaria RDT
SDFK40 was evaluated on a panel of stored (n = 341)
a n df r e s h( n=1 8 0 )w h o l eb l o o ds a m p l e s ,o b t a i n e di n
returned international travelers suspected of malaria.
Sensitivity was poor for P. falciparum samples at
low parasite densities, but excellent for detection of
P. falciparum at high parasite densities, as well as for
P. vivax and P. ovale.
The present study has its limitations. Although evalua-
tion of a RDT in a standardized laboratory is a logical
step preceding studies in field settings [15], it is clear
that conditions in a reference setting such as the present
one are more favorable compared to those in field set-
tings (e.g. temperature control, training and expertise of
staff). Another limitation was that, for the retrospective
samples, it was impossible to explore the cause of dis-
cordant results. Furthermore stringent criteria were
used. For instance, species mismatch was considered as
a false negative result, although the diagnosis of malaria
had been confirmed by the SDFK40: considering the
non-falciparum species that reacted not only with the
pan-pLDH line but also with the Pf-pLDH line as true
positives would have increased the sensitivity for
P. ovale to 84.6% (prospective study) and for P. malariae
to 35.7% (retrospective study). In addition, samples with
pure gametocytaemia were included among the P. falci-
parum samples [16]: assigning them to the Plasmodium
negative samples would have increased overall sensitivity
to 71.9% and 80.8% for the retro- and prospective sam-
ples respectively, at the expense however of a lower spe-
cificity (97.3%) in the retrospective panel. Another
limitation was that, in the prospective study only the
results of a single observer were considered, as a second
and a third observer could not always perform reading
within the given time. However, this probably has not
influenced test results as the retrospective study revealed
high inter-observer agreements. Finally, in the prospective
study there was no Plasmodium negative control group
(microscopy and RDT negative) included, precluding
calculation of diagnostic specificity and predictive values.
The SDFK40 has been evaluated in two other studies:
in the first round of RDT evaluation by the WHO,
detection of P. falciparum and P. vivax was assessed
using diluted samples at fixed parasite densities. Detec-
tion rates for P. falciparum and P. vivax were 29.1%
and 50.0% at low (200/μl) parasite densities and 96.2%
and 100.0% at high (2,000/μl and 5,000/μl) parasite
densities respectively [6]. In a field setting in Madagas-
car, overall sensitivities were 89.4% for the detection of
P. falciparum and 73.3% for the non-falciparum spe-
cies [17]. Conform the present study, there was a
higher detection rate for P. vivax (8/9 samples) com-
pared to P. malariae (3/6 samples).
Data assessing the test characteristics of pLDH RDTs
for non-falciparum infections are limited [18], but the
low sensitivity for diagnosis of P. malariae and P. ovale
is a well-known phenomenon among RDTs [16,19-21].
Unlike the previous studies, the present one included
samples of P. ovale. The high sensitivity of SDFK40 for
detection of P. ovale is remarkable and exceeds that of
other RDTs evaluated in non-endemic settings
[16,20-22] as well as that of the OptiMAL and SDFK60
run simultaneously. In the present setting at ITM, a
comparable sensitivity (76.3%) for P. ovale has only been
achieved for the SDFK60 [12]. Although species mis-
matches were rare and did not involve misidentification
of P. falciparum as non-falciparum species, the cross-
reaction of two P. malariae samples and one P. ovale
sample with the Pf-pLDH should be taken into account
and further studied.
The side-to-side comparison with the OptiMAL and
the SDFK60 revealed significantly lower overall sensi-
tivities for the detection of P. falciparum by the
SDFK40. HRP-2 is known to be detected at lower para-
site rates compared to pLDH [2] and this might explain
for the difference in sensitivity between the SDFK40
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P. falciparum samples at parasite density 0-100/μl,
compared to only 1/11 for the SDFK40. Compared to the
OptiMAL, the SDFK40 showed a lower sensitivity
for P. falciparum but a higher sensitivity for the non-
falciparum species, especially P. ovale. These differences
may be explained by differences in affinity of antibodies
[2] or by reaction conditions created by the buffer com-
position favoring the pan-pLDH antigen-antibody interac-
tion over that of Pf-pLDH in the case of the SDFK40.
From the present study, it is difficult to estimate the
incidence of false positive RDT results in the SDFK40:
in the retrospective part, none of the Plasmodium nega-
tive samples reacted positive. These samples had also
been tested negative by the routinely performed RDTs.
In contrast, the prospective panel included microscopy
negative samples that had given positive results with
o n eo rb o t ho ft h er o u t i n e l yu s e dR D T s( t h eS D F K 6 0
and the OptiMAL) for diagnostic work-up, which may
explain for discordance in false positive results between
the prospective and retrospective panel. Among these
samples, false positive reactions occurred less frequently
in the SDFK40 compared to the OptiMAL and the
SDFK60. For the SDFK60, persistence of HRP-2 may
explain for part of the false positive results. The pLDH
enzyme - expressed by viable parasites - declines rapidly
after therapy but is also expressed by gametocytes
[2,23]. Prospective monitoring of diagnostic characteris-
tics on large series will be needed to get reliable esti-
mates of the number of false positive SDFK40 results.
Test line intensities of the SDFK40 correlated to para-
site densities, but there was much overlap, precluding
reliance on line intensities as an indicator of parasite
density. The test line intensity of about one out of five
positive test lines was scored as faint. In the present
study, observers were trained to distinguish faint test
lines and to interpret them as positive; in field settings
however, disregarding faint test lines as negative is a
well known error that might interfere with correct read-
ing, especially at unfavorable light conditions [24-27].
Comparison of the retro- and prospective panels
revealed some differences. In the prospective panel, the
overall sensitivity of the SDFK40 for the diagnosis of
P. falciparum was higher as compared to the retrospec-
tive panel. This may be attributed to differences in para-
site density between both panels: 52.3% (90/172) of
P. falciparum samples in the retrospective panel had
ap a r a s i t ed e n s i t y≤ 1,000/μl compared to only 32.1%
(44/137) in the prospective panel (Tables 3 and 5),
whereas sensitivities at low (≤ 100/μl) and high (>1,000/
μl) parasite densities were similar for both panels.
Although the difference in parasite density appears to be
the most plausible explanation, an influence of sample
storage cannot be excluded. In a previous study [20], we
showed evidence for decline of parasite pLDH in the
case of P. ovale, but this effect was noted for samples
stored for extended periods (more than 8 years) which
were not included in the present study. Another differ-
ence was the presence of a single test line versus both
test lines in the case of P. falciparum samples: in the
retrospective panel, the majority of P. falciparum sam-
ples showed both Pf-pLDH and pan-pLDH lines, while
this proportion was significantly lower in the prospective
panel. The presence of a single Pf-pLDH line occurred
almost exclusively among samples tested with a single
lot (R081006). Lot number R081006 had been used in
the retrospective study for only one P. falciparum sam-
ple, making definite comparisons impossible; neverthe-
less a lot-related phenomenon is highly suggestive. Lot-
to-lot variability in RDTs is a well-known phenomenon
and is an issue in RDT performance monitoring and
quality control [6,7,28,29]: according to WHO guide-
lines, each new lot number of a RDT used in diagnosis
should be evaluated by a reference laboratory before
release [30].
Compared to HRP-2 RDTs, pLDH-based RDTs are
generally reported to have lower sensitivities for the
detection of P. falciparum, especially at parasite densi-
ties ≤ 100/μl [2,31,32]. In addition, pLDH RDTs have
been reported to be less resistant to heat degradation in
comparison to HRP-2 RDTs [33], although the SDFK40
package insert claims heat stability up to 40°C and the
heat stability testing of the WHO/FIND study confirmed
resistance to temperatures up to 45°C [6]. On the other
h a n d ,p L D HR D T sh a v ea d v a n t a g e so v e rt h eH R P - 2
based RDTs: as mentioned above, pLDH, unlike HRP-2,
does not persist long after treated or past P. falciparum
infections, and unlike HRP-2 based RDTs, they are not
susceptible to the prozone phenomenon, i.e. the occur-
rence of test negative or low-intensity test lines at ele-
vated parasite densities [9]. In addition, HRP-2 gene
deletions and polymorphisms have been described, pos-
sibly limiting the use of HRP-2 based antigen tests in
the affected areas [10,34,35]. For pLDH such genetic
variability has not been described [36].
For the non-endemic setting, the low sensitivity of the
SDFK40 for the detection of P. falciparum at parasite
densities below 1,000/μl is of concern and precludes its
use in routine diagnosis, as non-immune travelers may
be symptomatic at such low parasite densities [2]. How-
ever, the particular advantage of the SDFK40 in this set-
ting is its high sensitivity for both P. vivax and P. ovale,
but it should be used in conjunction with another brand
known for reliable detection of P. falciparum.
Conclusion
Challenged to a panel of clinical samples in a reference
setting, the SDFK40 showed a low sensitivity for
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≤ 100/μl, precluding its use as the only diagnostic tool
for malaria diagnosis. However, SDFK40 performed
excellent for P. falciparum samples at high (>1,000/μl)
parasite densities as well as for detection of P. vivax and
P. ovale at parasite densities >500/μl.
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